combination prednisone colchicine patients primary cholangitis Primary cholangitis cholestatic liver disease inflammation fibrosis biliary tract cause disease unknown effective medical treatment exists study patients combination low-dose prednisone mg/day colchicine bid course group concurrent historical controls months improvement liver test results baseline values patients prednisone colchicine untreated controls months significant differences biochemical tests untreated patients Analysis serial liver biopsies differences histologic change groups yr follow-up deaths control group none treated group untreated patients ascites gastrointestinal bleeding untreated patients developed ascites contrast treated group ascites patient combination colchicine prednisone histologic progression progression standard liver tests yr therapy trend clinical deterioration survival yr treatment basis findings empiric use drugs patients primary cholangitis PSC controlled clinical trial treatment incurable disease 